Xeris Biopharma Holdings, Inc.
XERS
$7.59
$0.020.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.45% | -18.40% | 3.20% | -10.53% | -11.20% |
| Total Receivables | 14.50% | 14.64% | -1.76% | -3.07% | 13.43% |
| Inventory | 27.69% | 9.37% | 6.77% | 4.98% | 5.13% |
| Prepaid Expenses | -1.18% | -19.02% | 4.36% | -2.92% | -3.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.51% | -2.49% | 2.99% | -4.43% | -1.70% |
|
|
|||||
| Total Current Assets | 13.51% | -2.49% | 2.99% | -4.43% | -1.70% |
| Net Property, Plant & Equipment | -0.37% | -1.49% | -0.56% | -1.14% | -0.39% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -2.82% | -2.74% | -2.67% | -2.60% | -2.53% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.71% | -5.71% | -0.66% | -0.93% | 19.07% |
| Total Assets | 6.10% | -2.35% | 0.61% | -3.20% | -1.45% |
|
|
|||||
| Total Accounts Payable | 48.96% | 177.38% | -69.27% | 28.51% | -18.27% |
| Total Accrued Expenses | 14.48% | -10.59% | 28.91% | -5.79% | 4.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -65.94% | -14.66% | 0.39% | 297.57% | 14.77% |
| Total Finance Division Other Current Liabilities | 7.83% | -1.54% | 9.62% | 4.47% | 7.30% |
| Total Other Current Liabilities | 7.83% | -1.54% | 9.62% | 4.47% | 7.30% |
| Total Current Liabilities | 0.10% | -5.35% | 10.36% | 20.57% | 3.29% |
|
|
|||||
| Total Current Liabilities | 0.10% | -5.35% | 10.36% | 20.57% | 3.29% |
| Long-Term Debt | 0.38% | 0.37% | 0.36% | -6.18% | 0.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.31% | -1.17% | -1.13% | -1.11% | -1.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 60.36% | 145.75% | -76.99% | -22.53% | 27.72% |
| Total Liabilities | 0.97% | -0.59% | 0.93% | -0.45% | 1.51% |
|
|
|||||
| Common Stock & APIC | 2.75% | 0.58% | 0.60% | 1.06% | 0.78% |
| Retained Earnings | -0.28% | -1.37% | -0.77% | -2.42% | -2.36% |
| Treasury Stock & Other | 4.00% | 0.00% | -56.25% | 48.39% | 13.89% |
| Total Common Equity | 45.05% | -18.62% | -4.56% | -46.86% | -110.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.05% | -18.62% | -4.56% | -46.86% | -110.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.05% | -18.62% | -4.56% | -46.86% | -110.13% |
|
|
|||||